CD8A and infection: A subsequent analysis of a DNA-prime, recombinant adenovirus–vectored vaccine trial (HVTN 505) showed that envelope-specific (Env-specific) CD8+ T cells with high-magnitude polyfunctionality were associated with reduced risk of infection (13), despite a lack of vaccine-induced protection overall (6).